Fairfax, Va., May 13, 2010 – The Radiation Oncology Institute (ROI) has hired Tracy Casteuble as its inaugural director, a position to which she brings 15 years of research and analysis experience.
Casteuble received her bachelor’s degree from the University of Virginia in Charlottesville, Va., and her M.B.A. from George Mason University in Fairfax, Va. Prior to joining the ROI, she directed research programs at the American Society of Association Executives and the Healthcare Distribution Management Association Foundation developing programs, research agendas and projects in cooperation with member boards and committees.
“I’m excited to welcome Tracy to the Radiation Oncology Institute,” Theodore Lawrence, M.D., Ph.D., FASTRO, ROI president, said. “She brings a wealth of experience to the table that I’m confident will help propel forward the goals and mission of ROI.”
At ROI, Casteuble will work in cooperation with the Board of Trustees and Research Committee to develop a national research agenda that will improve the practice of radiation oncology, develop reliable data about fundamental measures of the profession, and create common terminology for researchers and practitioners.
Casteuble said ROI is at a point where it can provide crucial primary and secondary research and analysis to further the profession and the issues and programs that the American Society for Radiation Oncology (ASTRO) champions.
“I enjoy the start-up aspect of ROI’s plans; that’s the time when all ideas are fresh, momentum and energy is high, and the sense of mission is strong,” she said. “It’s a great, creative time to be involved and part of the excitement when long-planned and awaited dreams come to fruition. I’m really looking forward to it.”
The Radiation Oncology Institute (ROI) is a non-profit, 501 (c)(3) foundation created in 2006 by the American Society for Radiation Oncology (ASTRO) Board of Directors to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. ROI strategically funds research on new and existing radiation therapy treatments to identify links between best practices and improved outcomes, to evaluate the efficacy and cost-benefit of radiation therapy and to foster multi-institutional research in radiation oncology. The ROI recently launched the National Radiation Oncology Registry (NROR) pilot program to collect standardized information about patient care to help inform quality improvement initiatives and provide meaningful benchmarks for the radiation oncology field.